Products
NOA-GAPMER™
NOA-NMD™
NOA-Switch™
Best AONs
Functional Panels
SpliceMod™
Science
Technology
Publications
Guidelines
Protocols
About
Vision
Story
Team
Contact
Splice
to discover
Splice
to understand
Deciphering the complexity of the transcriptome to illuminate cell physiology and disease pathology.
Our Products
NOA-Switch™
Transcript
switching
Antisense OligoNucleotides for switching target transcript to an alternate splice-isoform
Modulation of specific splice event
Transcript-specific switching
Phenotype-based validation of targets
Pathway-centric and gene-family options
Covers major types of splicing patterns
Example Paper
PTBP1-Mediated Alternative Splicing Regulates the Inflammatory Secretome and the Pro-tumorigenic Effects of Senescent Cells
Georgilis
et al
. 2018.
Cancer Cell
NOA-GAPmer™
Transcript
knock-down
Antisense OligoNucleotides for target transcript knockdown
Induction of RNase H degradation
Transcript-specific knockdown
Phenotype-based validation of targets
Pathway-centric and gene-family options
Overcomes off-target issues (e.g. siRNA)
Example Paper
Gapmer, siRNA, SSO and their effects on transcript knockdown efficiency
Bin Muzakar
et al
. 2021.
Manuscript in preparation
NOA-NMD™
Transcript
knock-down
Antisense OligoNucleotides for target transcript knockdown
Induction of Nonsense-Mediated Decay (NMD)
Transcript-specific knockdown
Phenotype-based validation of targets
Pathway-centric and gene-family options
Overcomes off-target issues (e.g. siRNA)
Example Paper
MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis
Koh
et al
. 2015.
Nature
0
+
NOA-Switch™
0
+
NOA-GAPmer™
0
+
NOA-NMD™
~
0
Antisense OligoNucleotides
>
0
%
Transcriptome coverage